Risks for childhood non-Hodgkin lymphoma

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. Childhood cancers are rare and there is less known about the risks. Most risks for childhood cancer are not modifiable. This means that you can’t change them.

Some children with genetic conditions have a higher than average risk for childhood non-Hodgkin lymphoma (NHL). Talk to the doctor about your child’s risk.

The following can increase the risk for childhood NHL. None of these risks can be changed. Until we learn more about these risks, there are no specific ways to lower the risk for childhood NHL.

Weak immune system

Epstein-Barr virus (EBV)

Weak immune system

Having a weak immune system (immunosuppression) increases the risk for childhood NHL. A child may have a weak immune system for different reasons, including if they have HIV (the virus that causes AIDS) or if they have had an organ transplant and must take medicines to suppress their immune system.

The following inherited conditions can also weaken the immune system and increase the risk of cancers such as childhood NHL.

Ataxia-telangiectasia (AT) affects the nervous system, immune system and other body systems. Signs and symptoms include loss of balance, poor coordination, frequent infections, red eyes (due to widening of blood vessels) and abnormal eye movements. AT is associated with an increased risk of developing some cancers, including leukemia and lymphoma.

Wiskott-Aldrich syndrome (WAS) affects the blood cells and the cells of the immune system. It usually only affects boys. WAS increases the risk of children developing Hodgkin lymphoma (HL), NHL and acute myelogenous leukemia (AML).

X-linked lymphoproliferative disease (XLP) affects the immune system so it has an abnormal response to an Epstein-Barr virus infection. This response can cause damage to the bone marrow, liver, spleen, heart and kidneys. It is more common in boys. XLP increases the risk of NHL in childhood and adulthood.

Chediak-Higashi syndrome affects both the immune and nervous systems. Children with Chediak-Higashi syndrome have a higher risk of certain cancers of the immune system, including NHL.

Severe combined immunodeficiency disorder (SCID) affects the immune system so that the white blood cells don’t work properly, causing serious infections. SCID increases the risk of childhood NHL.

Bloom syndrome is caused by mutations in a certain chromosome. Signs include shorter than average height, a high-pitched voice and a characteristic facial appearance.

Bloom syndrome is associated with an increased risk of developing cancer, including leukemia and lymphoma, and breast, cervical, colon, stomach, laryngeal and non-melanoma skin cancers, as well as Wilms tumour. People with Bloom syndrome often develop several different types of cancer.

Infection with Epstein-Barr virus (EBV)

Epstein-Barr virus (EBV) is a type of herpes virus that causes infectious mononucleosis (also called mono, or the kissing disease).

Children with EBV have a higher risk of developing Burkitt lymphoma. Burkitt lymphoma is a type of childhood NHL that is most often found in Africa, where children may also be infected with malaria. It is rare on other continents.

Learn more about Epstein-Barr virus (EBV).

Possible risks

The following have been linked with childhood NHL, but more research is needed to know for sure that they are risks:

  • exposure to pesticides
  • either parent smoking tobacco before conception or during pregnancy

Understanding your cancer risk

To make the decisions that are right for you, ask your doctor questions about risks. Learn how cancer can be prevented and what you can do to reduce your risk.

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • American Cancer Society. Risk Factors for Non-Hodgkin Lymphoma in Children. 2021. https://www.cancer.org/.
  • Cairo MS, Beishuizen A. Childhood, adolescent, and young adult non-Hodgkin lymphoma: current perspectives. British Journal of Haematology. 2019: 165(6):1021—1042.
  • PDQ Pediatric Treatment Editorial Board. Childhood Non-Hodgkin Lymphoma Treatment (PDQ®) – Health Professional Version . Bethesda, MD: National Cancer Institute; 2025. https://www.cancer.gov/.
  • Jacobson CA, Ng A, Aster JC, Freedman AS. Non-Hodgkin Lymphoma. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, [chapter 67], https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.
  • Gross TG, Kamdar KY, Bollard CM. Malignant Non-Hodgkin Lymphomas in Children. Blaney SM, Adamson PC, Helman LJ (eds.). Pizzo and Pollack's Pediatric Oncology . 8th ed. Wolters Kluwer; 2021: Kindle version, [chapter 19] https://read.amazon.ca/?asin=B08DVWZNVP&language=en-CA.
  • National Toxicology Program. Report on Carcinogens. 15 ed. Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service; 2021. https://ntp.niehs.nih.gov/whatwestudy/assessments/cancer/roc/index.html.
  • Roman E, Lightfoot T, Picton S, Kinsey S. Childhood cancers. Thun MJ, Linet MS, Cerhan JR, Haiman CA Schottenfeld D, eds.. Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: 59.
  • Yerigeri K, Buhtoiarov I. Pediatric-type follicular lymphoma in a Crohn's disease patient receiving anti-a4B7-integrin therapy: A case report. World Journal of Gastroenterology. 2023: 29(43):5865—5871.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society